Correction
Systematic identification of Celastrol-binding proteins reveals that Shoc2 is inhibited by Celastrol
Paper Information
Record ID:
41012
Author(s):
Journal:
Publication Date:
November 21, 2018
Retraction Date:
April 27, 2021
(4.6 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pharmacology
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pharmacology
Institutions:
- Department of Health Toxicology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, P.R. China
- The First Department of Endoscopy, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China
- Department of Environmental Hygiene, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, P.R. China
- Department of Health Toxicology, Faculty of Naval Medicine, Second Military Medical University, Shanghai 200433, P.R. China
Country:
šØš³ ChinaArticle Type:
Publisher:
Portland Press
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Correction Details
Citations (19)
19
Total Citations10
Post-Retraction(52.6%)
9
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
3
After 2+ years
1456
Days since retraction (latest)
Emerging Target Discovery Strategies Drive the Decoding of Therapeutic Power of Natural Products and Further Drug Development: A Case Study of Celastrol
Yanbei Tu, Guiyu Dai, Yanyan Chen et al. (6 authors)
Exploration
Open Access
Published: Apr 2025
1 citation
1 citation
1456 days after retraction
Celastrol induces DNA damage and cell death in BCR-ABL T315I-mutant CML by targeting YY1 and HMCES
Fan Yang, Hongchao Zhou, Piao Luo et al. (16 authors)
Phytomedicine
Published: Aug 2024
2 citations
2 citations
1199 days after retraction
RAS and SHOC2 Roles in RAF Activation and Therapeutic Considerations
Daniel A. Bonsor, Dhirendra K. Simanshu
Annual Review of Cancer Biology
Published: Dec 2023
4 citations
4 citations
953 days after retraction
Data from SHOC2 Is a Critical Modulator of Sensitivity to EGFRāTKIs in NonāSmall Cell Lung Cancer Cells
Hideki Terai, Junko Hamamoto, Katsura Emoto et al. (18 authors)
Unknown Journal
Open Access
Published: Apr 2023
706 days after retraction
Telotristat Etiprate alleviates rheumatoid arthritis by targeting LGALS3 and affecting MAPK signaling
Ling Zhang, Yanwen Lin, Xinrui Xu et al. (6 authors)
Intractable & Rare Diseases Research
Open Access
Published: Feb 2023
4 citations
4 citations
654 days after retraction
Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical developmentāa narrative review
Mariacarmela SantarpĆa, Giuliana Ciappina, Calogera Claudia Spagnolo et al. (10 authors)
Translational Lung Cancer Research
Open Access
Published: Feb 2023
34 citations
34 citations
645 days after retraction
Structural Advancement in Shoc2āMAPK Signaling Pathways in the Treatment of Cancer and Other Diseases
Udeep Chawla, Deepak Chopra
ChemistrySelect
Published: Dec 2022
603 days after retraction
Celastrol inhibits lung cancer growth by triggering histone acetylation and acting synergically with HDAC inhibitors
Geer Chen, Xiaoyu Zhu, Jiaqi Li et al. (15 authors)
Pharmacological Research
Open Access
Published: Oct 2022
24 citations
24 citations
524 days after retraction
Evidence for Anticancer Effects of Chinese Medicine Monomers on Colorectal Cancer
Tian-Hao Guo, Yuan Li, Shengwei Hong et al. (8 authors)
Chinese Journal of Integrative Medicine
Published: Apr 2022
9 citations
9 citations
351 days after retraction
Celastrol and Melatonin Modify SIRT1, SIRT6 and SIRT7 Gene Expression and Improve the Response of Human Granulosa-Lutein Cells to Oxidative Stress
Rita MartĆn-RamĆrez, Rebeca GonzĆ”lez-FernĆ”ndez, Jairo HernĆ”ndez et al. (6 authors)
Antioxidants
Open Access
Published: Nov 2021
17 citations
17 citations
211 days after retraction
Assessment of NR4A Ligands That Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1
Paola MunozāTello, Hua Lin, Pasha M. Khan et al. (6 authors)
Journal of Medicinal Chemistry
Open Access
Published: Dec 2020
55 citations
55 citations
140 days before retraction
SHOC2 Is a Critical Modulator of Sensitivity to EGFRāTKIs in NonāSmall Cell Lung Cancer Cells
Hideki Terai, Junko Hamamoto, Katsura Emoto et al. (18 authors)
Molecular Cancer Research
Open Access
Published: Oct 2020
17 citations
17 citations
183 days before retraction
Techniques and Strategies for Potential Protein Target Discovery and Active Pharmaceutical Molecule Screening in a Pandemic
Hongxin Yu, Chunyan Li, Xing Wang et al. (11 authors)
Journal of Proteome Research
Open Access
Published: Sep 2020
13 citations
13 citations
217 days before retraction
The leucineārich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease
Hyein Jang, Payton D. Stevens, Tianyan Gao et al. (4 authors)
FEBS Journal
Open Access
Published: Jun 2020
29 citations
29 citations
314 days before retraction
Assessment of NR4A Ligands that Directly Bind and Modulate the Orphan Nuclear Receptor Nurr1
Paola MunozāTello, Hua Lin, Pasha M. Khan et al. (6 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2020
4 citations
4 citations
337 days before retraction
Complementary and Alternative Treatments for Cancer Prevention and Cure [Part 1]
Abdul Kader Mohiuddin
Cancer Research and Cellular Therapeutics
Open Access
Published: Nov 2019
1 citation
1 citation
525 days before retraction
Mechanism of action of celastrol against rheumatoid arthritis: A network pharmacology analysis
Xinqiang Song, Yu Zhang, Erqin Dai et al. (5 authors)
International Immunopharmacology
Published: Jul 2019
55 citations
55 citations
665 days before retraction
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Abdul Kader Mohiuddin
Journal of Experimental and Clinical Toxicology
Open Access
Published: Feb 2019
1 citation
1 citation
815 days before retraction
Alternative Treatments for Cancer Prevention and Cure [Part 1]
Abdul Kader Mohiuddin
Advances in Pharmacology & Clinical Trials
Open Access
Published: Jan 2019
847 days before retraction
Quick Stats
Total Citations:
19
Years Since Retraction:
4.6 years
Open Access:
Yes
Last Checked:
Jul 24, 2025